Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-17

FDA Approved: LIDOCAINE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lidocaine patch 5% (Lidocaine) by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine Patch 5% (Lidoderm) (Lidocaine patch 5%)

Snippet

SUPPL AP for LIDOCAINE (LIDOCAINE)